<code id='78D5393004'></code><style id='78D5393004'></style>
    • <acronym id='78D5393004'></acronym>
      <center id='78D5393004'><center id='78D5393004'><tfoot id='78D5393004'></tfoot></center><abbr id='78D5393004'><dir id='78D5393004'><tfoot id='78D5393004'></tfoot><noframes id='78D5393004'>

    • <optgroup id='78D5393004'><strike id='78D5393004'><sup id='78D5393004'></sup></strike><code id='78D5393004'></code></optgroup>
        1. <b id='78D5393004'><label id='78D5393004'><select id='78D5393004'><dt id='78D5393004'><span id='78D5393004'></span></dt></select></label></b><u id='78D5393004'></u>
          <i id='78D5393004'><strike id='78D5393004'><tt id='78D5393004'><pre id='78D5393004'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:6268
          Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT
          Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

          WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

          The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

          advertisement

          The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Buoyed by wins on obesity, Novo Nordisk eyes heart disease
          Buoyed by wins on obesity, Novo Nordisk eyes heart disease

          AdobePHILADELPHIA—NovoNordisk,whichhasdominatedthediabetesandobesitymarketswithitsblockbusterdrugsOz

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          CRISPR pioneers react to Casgevy, first gene

          CRISPRpioneersJenniferDoudnaandFengZhangIllustration:STAT;Photos:AP,GettyTherevolutionstartedinsilen